Daily as of 2 Nov 16:00 ET
- Price
- below both $3.21 vs 50 $3.31 / 200 $3.21
- Projection
- ๐Death cross projected in 5 bars
- Test
- No active test
- Last cross
- ๐จGolden cross 10 Mar 2026 ยท projected 23 bars out
C4 Therapeutics (CCCC) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2021.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Mar 2026, but the two have been closing on each other and a death cross is projected within 10 bars. On both the weekly and the 4-hour, price sits between the 50 and the 200; on the daily it is below both.
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 22 Sep 2026 | ๐Death | 4-hour | 25 bars out | Not tested |
| 10 Mar 2026 | ๐จGolden moderate | daily | 23 bars out | Not tested |
| 9 Mar 2026 | ๐จGolden | 4-hour | 22 bars out | Not tested |
| 13 Feb 2026 | ๐Death steep | daily | 29 bars out | 3 bar cross test |
| 18 Dec 2025 | ๐Death | 4-hour | 28 bars out | Not tested |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.